EMA Withdrawn: Paxene (paclitaxel) — Norton Healthcare Ltd.

View source ↗

Summary

Paxene (paclitaxel) is withdrawn from consideration by Norton Healthcare Ltd., affecting indications including sarcoma (Kaposi), non-small cell lung carcinoma, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Neoplasms
• Carcinoma of the Lung Non-small Cell
• Ovarian Neoplasms
• Sarcoma Kaposi

Drugs mentioned

• Paxene (paclitaxel)

Snippet

Status: Withdrawn. Therapeutic area: Sarcoma, Kaposi;Carcinoma, Non-Small-Cell Lung;Ovarian Neoplasms;Breast Neoplasms. MAH: Norton Healthcare Ltd.. Decision date: 14/07/2009